|Series B, 2/13 |
Medical Research Commercialisation Fund (MRCF)
Brandon Biosciences Fund 1 (BBF1)
PolyActiva, a Melbourne, Australia-based biotechnology company. Founded in 2011 and led by Dr Russell Tait, CEO, PolyActiva has developed proprietary drug-polymer conjugate technology that enables site-specific drug delivery from medical device components such as ocular implants, intra-articular gel implants, and drug-eluting fibers.